Erratum: Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target (Science Translational Medicine (2018) DOI: 10.1126/scitranslmed.aap9840)

D. Liu, C. C. Wong, L. Fu, H. Chen, L. Zhao, C. Li, Y. Zhou, Y. Zhang, W. Xu, Y. Yang, B. Wu, G. Cheng, P. B.S. Lai, N. Wong, J. J.Y. Sung, J. Yu

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the Research Article "Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target," the missing accession number has been added to the Data and materials availability section of the article. The PDF and HTML (full text) have been corrected.

Original languageEnglish
Article numbereaav4522
JournalScience Translational Medicine
Volume10
Issue number460
DOIs
StatePublished - Sep 26 2018

Bibliographical note

Publisher Copyright:
Copyright © 2018 The Authors.

ASJC Scopus subject areas

  • Medicine (all)

Fingerprint

Dive into the research topics of 'Erratum: Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target (Science Translational Medicine (2018) DOI: 10.1126/scitranslmed.aap9840)'. Together they form a unique fingerprint.

Cite this